O'Brien Siobhán, Baumgartner Michael, Hall Alex R
Department of Evolution, Ecology and Behaviour, University of Liverpool, Liverpool L69 7ZB, UK.
Department of Environmental Systems Science, Institute of Integrative Biology, ETH Zürich, 8092 Zürich, Switzerland.
Evol Med Public Health. 2021 Jun 24;9(1):256-266. doi: 10.1093/emph/eoab020. eCollection 2021.
Slowing the spread of antimicrobial resistance is urgent if we are to continue treating infectious diseases successfully. There is increasing evidence microbial interactions between and within species are significant drivers of resistance. On one hand, cross-protection by resistant genotypes can shelter susceptible microbes from the adverse effects of antibiotics, reducing the advantage of resistance. On the other hand, antibiotic-mediated killing of susceptible genotypes can alleviate competition and allow resistant strains to thrive (competitive release). Here, by observing interactions both within and between species in microbial communities sampled from humans, we investigate the potential role for cross-protection and competitive release in driving the spread of ampicillin resistance in the ubiquitous gut commensal and opportunistic pathogen .
Using anaerobic gut microcosms comprising embedded within gut microbiota sampled from humans, we tested for cross-protection and competitive release both within and between species in response to the clinically important beta-lactam antibiotic ampicillin.
While cross-protection gave an advantage to antibiotic-susceptible in standard laboratory conditions (well-mixed LB medium), competitive release instead drove the spread of antibiotic-resistant in gut microcosms (ampicillin boosted growth of resistant bacteria in the presence of susceptible strains).
Competition between resistant strains and other members of the gut microbiota can restrict the spread of ampicillin resistance. If antibiotic therapy alleviates competition with resident microbes by killing susceptible strains, as here, microbiota-based interventions that restore competition could be a key for slowing the spread of resistance.
Slowing the spread of global antibiotic resistance is an urgent task. In this paper, we ask how interactions between microbial species drive the spread of resistance. We show that antibiotic killing of susceptible microbes can free up resources for resistant microbes and allow them to thrive. Therefore, we should consider microbes in light of their social interactions to understand the spread of resistance.
若要继续成功治疗传染病,减缓抗菌药物耐药性的传播迫在眉睫。越来越多的证据表明,物种之间及物种内部的微生物相互作用是耐药性的重要驱动因素。一方面,抗性基因型的交叉保护可使易感微生物免受抗生素的不利影响,降低抗性优势。另一方面,抗生素介导的易感基因型杀灭可减轻竞争,使抗性菌株得以繁衍(竞争释放)。在此,通过观察从人类样本中获取的微生物群落内物种之间及物种内部的相互作用,我们研究了交叉保护和竞争释放在驱动无处不在的肠道共生菌和机会致病菌氨苄西林耐药性传播中的潜在作用。
使用包含从人类肠道微生物群中提取的[具体内容缺失]的厌氧肠道微观模型,我们测试了针对临床重要的β-内酰胺抗生素氨苄西林,物种内部及物种之间的交叉保护和竞争释放情况。
虽然在标准实验室条件下(充分混合的LB培养基)交叉保护赋予了抗生素敏感型[具体内容缺失]优势,但在肠道微观模型中竞争释放反而推动了抗生素抗性[具体内容缺失]的传播(在存在易感菌株的情况下,氨苄西林促进了抗性细菌的生长)。
抗性菌株与肠道微生物群其他成员之间的竞争可限制氨苄西林耐药性的传播。如果抗生素治疗通过杀灭易感菌株减轻了与常驻微生物的竞争,如此处所示,恢复竞争的基于微生物群的干预措施可能是减缓耐药性传播的关键。
减缓全球抗生素耐药性的传播是一项紧迫任务。在本文中,我们探讨了微生物物种间的相互作用如何驱动耐药性的传播。我们发现抗生素杀灭易感微生物可为抗性微生物释放资源并使其得以繁衍。因此,我们应根据微生物的社会相互作用来理解耐药性的传播。